Your browser doesn't support javascript.
loading
Identification of the Immunological Changes Appearing in the CSF During the Early Immunosenescence Process Occurring in Multiple Sclerosis.
Picón, Carmen; Tejeda-Velarde, Amalia; Fernández-Velasco, José Ignacio; Comabella, Manuel; Álvarez-Lafuente, Roberto; Quintana, Ester; Sainz de la Maza, Susana; Monreal, Enric; Villarrubia, Noelia; Álvarez-Cermeño, José Carlos; Domínguez-Mozo, María Inmaculada; Ramió-Torrentà, Lluís; Rodríguez-Martín, Eulalia; Roldán, Ernesto; Aladro, Yolanda; Medina, Silvia; Espiño, Mercedes; Masjuan, Jaime; Matute-Blanch, Clara; Muñoz-San Martín, Marta; Espejo, Carmen; Guaza, Carmen; Muriel, Alfonso; Costa-Frossard, Lucienne; Villar, Luisa María.
Afiliação
  • Picón C; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Tejeda-Velarde A; Department of Brain Science, Imperial College London, London, United Kingdom.
  • Fernández-Velasco JI; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Comabella M; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Álvarez-Lafuente R; Servei de Neurologia-Neuroimmunologia, Centre d' Esclerosi Múltiple de Catalunya (Cemcat), Vall d' Hebron Institut de Recerca, Hospital Universitari Vall d' Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Quintana E; Department of Neurology, Hospital Clínico San Carlos, Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), REEM, Madrid, Spain.
  • Sainz de la Maza S; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Medical Sciences Department, Universitat de Girona, REEM, Girona, Spain.
  • Monreal E; Department of Neurology, Hospital Universitario Ramón y Cajal, IRYCIS, REEM, Madrid, Spain.
  • Villarrubia N; Department of Neurology, Hospital Universitario Ramón y Cajal, IRYCIS, REEM, Madrid, Spain.
  • Álvarez-Cermeño JC; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Domínguez-Mozo MI; Department of Neurology, Hospital Universitario Ramón y Cajal, IRYCIS, REEM, Madrid, Spain.
  • Ramió-Torrentà L; Department of Neurology, Hospital Clínico San Carlos, Madrid, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), REEM, Madrid, Spain.
  • Rodríguez-Martín E; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Medical Sciences Department, Universitat de Girona, REEM, Girona, Spain.
  • Roldán E; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Aladro Y; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Medina S; Department of Neurology, Hospital Universitario de Getafe, REEM, Madrid, Spain.
  • Espiño M; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Masjuan J; Department of Immunology, Hospital Universitario Ramón y Cajal, Instituto Ramón y Cajal de Investigacón Sanitaria (IRYCIS), Red Española de Esclerosis Múltiple (REEM), Madrid, Spain.
  • Matute-Blanch C; Department of Neurology, Hospital Universitario Ramón y Cajal, IRYCIS, REEM, Madrid, Spain.
  • Muñoz-San Martín M; Servei de Neurologia-Neuroimmunologia, Centre d' Esclerosi Múltiple de Catalunya (Cemcat), Vall d' Hebron Institut de Recerca, Hospital Universitari Vall d' Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Espejo C; Neuroimmunology and Multiple Sclerosis Unit, Department of Neurology, Hospital Dr. Josep Trueta, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Medical Sciences Department, Universitat de Girona, REEM, Girona, Spain.
  • Guaza C; Servei de Neurologia-Neuroimmunologia, Centre d' Esclerosi Múltiple de Catalunya (Cemcat), Vall d' Hebron Institut de Recerca, Hospital Universitari Vall d' Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Muriel A; Neuroimmunology Group, Functional and Systems Neurobiology Department, Instituto Cajal, CSIC, Madrid, Spain.
  • Costa-Frossard L; Clinical Biostatistics Unit, Hospital Universitario Ramón y Cajal, IRYCIS, CIBERESP, Nursing Department, Universidad de Alcalá, Madrid, Spain.
  • Villar LM; Department of Neurology, Hospital Universitario Ramón y Cajal, IRYCIS, REEM, Madrid, Spain.
Front Immunol ; 12: 685139, 2021.
Article em En | MEDLINE | ID: mdl-34322119
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bandas Oligoclonais / Imunossenescência / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bandas Oligoclonais / Imunossenescência / Esclerose Múltipla Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Front Immunol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha